Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Ixico (IXI) Share Price

Price 9.10p on 09-07-2026 at 16:45:13
Change 0.00p 0%
Buy 9.50p
Sell 8.70p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 54,951.00 at 9.099p
Day's Volume: 74,469
Last Close: 9.10p
Open: 9.10p
ISIN: GB00BFXR4C20
Day's Range 9.10p - 9.10p
52wk Range: 6.625p - 15.00p
Market Capitalisation: £19.93m
VWAP: 9.086808p
Shares in Issue: 218.97m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Ixico (IXI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 54,951 9.099p Ordinary
 12:00:48 - 09-Jul-26
Sell* 5,451 9.099p Ordinary
 10:21:07 - 09-Jul-26
Sell* 10,957 9.099p Ordinary
 09:41:44 - 09-Jul-26
Buy* 105 9.50p SI Trade
 09:15:11 - 09-Jul-26
Buy* 26 9.50p SI Trade
 09:15:11 - 09-Jul-26
Buy* 104 9.50p SI Trade
 09:15:11 - 09-Jul-26
Sell* 350 8.70p SI Trade
 09:15:11 - 09-Jul-26
Buy* 25 9.50p SI Trade
 09:15:11 - 09-Jul-26
Sell* 2,500 8.75p Ordinary
 08:28:21 - 09-Jul-26
Sell* 989 9.099p Ordinary
 14:58:19 - 08-Jul-26
See more Ixico trades

Ixico (IXI) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Jul 2026 (Wed) 9.10 9.10 9.10 9.10 24,702
7th Jul 2026 (Tue) 8.50 9.10 8.50 9.10 450,421
6th Jul 2026 (Mon) 8.25 8.25 8.125 8.125 32,027
3rd Jul 2026 (Fri) 8.25 8.25 8.20 8.25 32,224
2nd Jul 2026 (Thu) 8.25 8.25 8.25 8.25 81,657
1st Jul 2026 (Wed) 8.30 8.30 8.25 8.25 7,600
30th Jun 2026 (Tue) 8.45 8.45 8.30 8.30 86,424
29th Jun 2026 (Mon) 8.45 8.45 8.45 8.45 4,482
26th Jun 2026 (Fri) 8.45 8.45 8.45 8.45 154
25th Jun 2026 (Thu) 8.45 8.45 8.45 8.45 958
24th Jun 2026 (Wed) 8.45 8.45 8.45 8.45 200
23rd Jun 2026 (Tue) 8.45 8.45 8.45 8.45 13,109
22nd Jun 2026 (Mon) 8.65 8.65 8.45 8.45 5,841
19th Jun 2026 (Fri) 8.50 8.65 8.50 8.65 3,798
18th Jun 2026 (Thu) 8.65 8.65 8.65 8.65 23,810
17th Jun 2026 (Wed) 8.75 8.75 8.65 8.65 82,628
16th Jun 2026 (Tue) 8.75 8.75 8.75 8.75 27,634
15th Jun 2026 (Mon) 8.75 8.75 8.75 8.75 38,146
12th Jun 2026 (Fri) 8.65 8.65 8.65 8.65 52,900
11th Jun 2026 (Thu) 8.65 8.65 8.65 8.65 6,798
10th Jun 2026 (Wed) 8.65 8.65 8.65 8.65 18,439
9th Jun 2026 (Tue) 8.65 8.65 8.65 8.65 6,980
See more Ixico price history

Ixico (IXI) Regulatory News

Date Source Headline
7th Jul 2026 7:00 am RNS Trading Update
19th Jun 2026 7:00 am RNS Exercise of Options
8th Jun 2026 7:00 am RNS Scientific advisors & partners update
22nd May 2026 7:00 am RNS-R Company presentation at Mello 2026
21st May 2026 7:00 am RNS Contract win and contract extension
19th May 2026 7:00 am RNS Interim results for six months ending 31/03/2026
12th May 2026 7:00 am RNS IXICO Updates AI Neuroimaging Platform
28th Apr 2026 2:31 pm RNS Holding(s) in Company
28th Apr 2026 1:50 pm RNS Holding(s) in Company
28th Apr 2026 11:45 am RNS Holding(s) in Company
See more Ixico regulatory news

Ixico (IXI) Share News

TRADING UPDATES: Ixico ups guidance; Steppe Cement revenue up

7th Jul 2026 13:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations

7th Jul 2026 11:35

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

TRADING UPDATES: BTG to beat expectations; Sabre backs outlook

21st May 2026 14:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Ixico reaffirms growth guidance as half-year revenue rises

19th May 2026 15:00

Ixico PLC - London-based medical research company, focused on analysing trial data using neuroscience imaging and biomarkers - Reports results for the six months ended March 31. Revenue increases 23% to GBP3.9 million from GBP3.2 million the year before, "driven by new contract wins, contract extensions and an increased volume of analyses". Pretax loss widens to GBP1.6 million from GBP889,000. Sales and marketing expenses increase 23% to GBP1.1 million from GBPGBP862,000, with total operating expenses increasing 19% to GBP3.3 million from GBP2.8 million. Order book totals GBP18.1 million at March 31, up from GBP13.1 million one year prior. Company reaffirms guidance of 15% revenue growth for the full year. Chief Executive Officer Bram Goorden says Ixico "is now in a more stable and resilient position" and "is well placed to deliver on its ambitions and create sustainable value in the years ahead." Read More

WINNERS & LOSERS: Forterra falls; Thor Explorations earnings up

19th May 2026 10:02

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

See more Ixico news
FTSE 100 Latest
Value10,472.45
Change-16.59

Login to your account

Forgot Password?

Not Registered